Valmark Advisers Inc. Has $439,000 Stock Position in Danaher Corporation $DHR

Valmark Advisers Inc. cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 6.1% during the second quarter, Holdings Channel reports. The fund owned 2,221 shares of the conglomerate’s stock after selling 144 shares during the quarter. Valmark Advisers Inc.’s holdings in Danaher were worth $439,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Hills Bank & Trust Co boosted its position in shares of Danaher by 0.3% during the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock valued at $3,693,000 after buying an additional 53 shares during the last quarter. Worth Financial Advisory Group LLC boosted its position in shares of Danaher by 4.6% during the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after buying an additional 53 shares during the last quarter. Sageworth Trust Co boosted its position in shares of Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock valued at $493,000 after buying an additional 54 shares during the last quarter. 1834 Investment Advisors Co. boosted its position in shares of Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after buying an additional 54 shares during the last quarter. Finally, Bruce G. Allen Investments LLC boosted its position in shares of Danaher by 13.1% during the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after buying an additional 54 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of Danaher stock opened at $204.31 on Friday. Danaher Corporation has a one year low of $171.00 and a one year high of $279.41. The stock’s fifty day moving average is $200.55 and its 200 day moving average is $197.32. The stock has a market cap of $146.29 billion, a P/E ratio of 43.47, a P/E/G ratio of 2.92 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same period last year, the firm earned $1.72 EPS. Danaher’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on DHR shares. Barclays restated an “overweight” rating and issued a $225.00 price target (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Wells Fargo & Company dropped their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Evercore ISI raised their price target on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research note on Tuesday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research note on Wednesday. Seventeen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $244.60.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.